2024 ICD-10-CM Diagnosis Code T38.7X4D

Poisoning by androgens and anabolic congeners, undetermined, subsequent encounter

ICD-10-CM Code:
T38.7X4D
ICD-10 Code for:
Poisoning by androgens and anabolic congeners, undet, subs
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified
        (T38)

T38.7X4D is a billable diagnosis code used to specify a medical diagnosis of poisoning by androgens and anabolic congeners, undetermined, subsequent encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

T38.7X4D is a subsequent encounter code, includes a 7th character and should be used after the patient has completed active treatment for a condition like poisoning by androgens and anabolic congeners undetermined. According to ICD-10-CM Guidelines a "subsequent encounter" occurs when the patient is receiving routine care for the condition during the healing or recovery phase of treatment. Subsequent diagnosis codes are appropriate during the recovery phase, no matter how many times the patient has seen the provider for this condition. If the provider needs to adjust the patient's care plan due to a setback or other complication, the encounter becomes active again.

Clinical Classification

Clinical Information

  • Androsterone

    a metabolite of testosterone or androstenedione with a 3-alpha-hydroxyl group and without the double bond. the 3-beta hydroxyl isomer is epiandrosterone.
  • Glucuronosyltransferase

    a family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. they function as drug-metabolizing enzymes that catalyze the conjugation of udpglucuronic acid to a variety of endogenous and exogenous compounds. ec 2.4.1.17.
  • Ethylestrenol

    an anabolic steroid with some progestational activity and little androgenic effect.
  • Norethandrolone

    a synthetic hormone with anabolic and androgenic properties and moderate progestational activity.
  • Fluoxymesterone

    an anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.
  • Mesterolone

    17 beta-hydroxy-1 alpha-methyl-5 alpha-androstan-3-one. a synthetic steroid with anabolic and androgenic activities.
  • Methandriol

    a synthetic steroid with anabolic and androgenic properties. (from martindale, the extra pharmacopoeia, 30th ed, p1188)
  • Methandrostenolone

    a synthetic steroid with anabolic properties that are more pronounced than its androgenic effects. it has little progestational activity. (from martindale, the extra pharmacopoeia, 30th ed, p1188)
  • Methenolone

    a synthetic steroid that has been used for its anabolic action.
  • Methyltestosterone

    a synthetic hormone used for androgen replacement therapy and as an hormonal antineoplastic agent (antineoplastic agents, hormonal).
  • Nandrolone

    c18 steroid with androgenic and anabolic properties. it is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position.
  • Nandrolone Decanoate

    decanoic acid ester of nandrolone that is used as an anabolic agent to prevent or treat wasting syndrome associated with severe chronic illness or hiv infection (hiv wasting syndrome). it may also be used in the treatment of postmenopausal osteoporosis.
  • Oxandrolone

    a synthetic hormone with anabolic and androgenic properties.
  • Oxymetholone

    a synthetic hormone with anabolic and androgenic properties. it is used mainly in the treatment of anemias. according to the fourth annual report on carcinogens (ntp 85-002), this compound may reasonably be anticipated to be a carcinogen. (from merck index, 11th ed)
  • Stanozolol

    a synthetic steroid that has anabolic and androgenic properties. (from martindale, the extra pharmacopoeia, 30th ed, p1194)
  • Testolactone

    an antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.
  • 17-Hydroxysteroid Dehydrogenases

    a class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. ec 1.1.-.
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase

    an enzyme that catalyzes the reduction of testosterone to 5-alpha dihydrotestosterone.
  • 5-alpha Reductase Inhibitors

    drugs that inhibit 3-oxo-5-alpha-steroid 4-dehydrogenase. they are commonly used to reduce the production of dihydrotestosterone.
  • Clusterin

    a highly conserved heterodimeric glycoprotein that is differentially expressed during many severe physiological disturbance states such as cancer; apoptosis; and various neurological disorders. clusterin is ubiquitously expressed and appears to function as a secreted molecular chaperone.
  • Receptors, Androgen

    proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. the complex of the androgen and receptor migrates to the cell nucleus where it induces transcription of specific segments of dna.
  • Sex Hormone-Binding Globulin

    a glycoprotein migrating as a beta-globulin. its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. the protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. sex hormone-binding protein has the same amino acid sequence as androgen-binding protein. they differ by their sites of synthesis and post-translational oligosaccharide modifications.
  • Steroid 16-alpha-Hydroxylase

    a liver microsomal cytochrome p450 enzyme that catalyzes the 16-alpha-hydroxylation of a broad spectrum of steroids, fatty acids, and xenobiotics in the presence of molecular oxygen and nadph-ferrihemoprotein reductase. this enzyme is encoded by a number of genes from several cyp2 subfamilies.
  • Testosterone

    a potent androgenic steroid and major product secreted by the leydig cells of the testis. its production is stimulated by luteinizing hormone from the pituitary gland. in turn, testosterone exerts feedback control of the pituitary lh and fsh secretion. depending on the tissues, testosterone can be further converted to dihydrotestosterone or estradiol.
  • Testosterone Congeners

    steroidal compounds related to testosterone, the major mammalian male sex hormone. testosterone congeners include important testosterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with androgenic activities.
  • Testosterone Propionate

    an ester of testosterone with a propionate substitution at the 17-beta position.
  • Zeranol

    a non-steroidal estrogen analog.

Coding Guidelines

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (T38). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Present on Admission (POA)

T38.7X4D is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert T38.7X4D to ICD-9-CM

  • ICD-9-CM Code: V58.89 - Other specfied aftercare
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Drugs and Chemicals

The parent code T38.7X4 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
Anabolic steroidT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrogenT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Androgen-estrogen mixtureT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrostaloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrostanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
AndrosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
CalusteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Chlorodehydro-methyltestosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Congener, anabolicT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
DromostanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
DrostanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
DurabolinT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
EpitiostanolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
EstanozololT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
EthylestrenolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
FluoxymesteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MacrolideT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Macrolide
  »anabolic drug
T38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Macrolide
  »antibiotic
T38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MepitiostaneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MestanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MesteroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MetandienoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MetandrostenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MetenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethandienoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethandriolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethandrostenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethenoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
MethyltestosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
NandroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
NorethandroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
Nortestosterone (furanpropionate)T38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
OxandroloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
OxymesteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
OxymetholoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
PrasteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
StanoloneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
StanozololT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
TestolactoneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
TestosteroneT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6
ZeranolT38.7X1T38.7X2T38.7X3T38.7X4T38.7X5T38.7X6

Patient Education


Poisoning

A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:

  • Prescription or over-the-counter medicines taken in doses that are too high
  • Overdoses of illegal drugs
  • Carbon monoxide from gas appliances
  • Household products, such as laundry powder or furniture polish
  • Pesticides
  • Indoor or outdoor plants
  • Metals such as lead and mercury

The effects of poisoning range from short-term illness to brain damage, coma, and death. To prevent poisoning it is important to use and store products exactly as their labels say. Keep dangerous products where children can't get to them. Treatment for poisoning depends on the type of poison. If you suspect someone has been poisoned, call your local poison control center at 1-800-222-1222 right away.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.